By Maureen Meehan
A modern clinical demo conducted by Soroka University Health care Center and Israeli clinical cannabis company Cannbit-Tikun Olam (TASE:TKUN) showed promising final results, in particular for treating post-traumatic strain disorder (PTSD), reported the Jerusalem Article.
Notably, a selection of cannabis-medicated individuals stopped or lowered their dosages of opioids by 52%, anti-psychotics by 36.9%, anti-epileptics by 35.7% and hypnotics and sedatives by 35.3%. Over-all, more than two-thirds of individuals described at least average enhancement with no really serious side results, with 90.8% of dealt with PTSD patients being categorised as therapeutic successes after 6 months.
Picture by ipopba/Getty Illustrations or photos
Connected: Military Veterans Can Use Medical Marijuana Without Losing Eligibility For Treatment And Companies
Other benefits included a decrease in rage assaults, restlessness, nausea and slumber disturbances. Practically 50 percent of the sufferers claimed that their high-quality of daily life experienced improved during the time of remedy.
The examine, conducted above numerous many years, focused on 8,500 male and female Israelis, averaging 54.6 years previous, making use of cannabis strains made by Cannbit-Tikun Olam.
“In the earlier, we previously shown that treatment method with clinical hashish products relieves signs or symptoms and enhances top quality of lifetime for people,” said Lihi Bar-Lev Schleider the company’s head of R&D. “This is the 1st time that in-depth, structured and systematic analysis of a large volume of details on a very huge group of sufferers was carried out, and in which, without having bias, the effect of the therapy for many indications was examined.”
In December very last year, an exclusive and mutual collaboration arrangement was signed by Cannbit-Tikun Olam and Teva Pharmaceuticals, whereby the former’s products will be dispersed by the latter all over Israel and the Palestinian Authority.
“The healthcare hashish arena is building and remaining professionalized at a dizzying speed in Israel, and there is a lot more openness to it in Israel and throughout the world,” Teva Israel CEO Yossi Ofek said.
Linked: PTSD People Report On Efficacy Of Professional medical Cannabis
“Today, it is crystal clear to lots of in the pharmaceutical market and in the clinical group that the use of oils created from specific hashish strains could supply extra cure solutions and respond to unmet medical needs of sufferers. I have no question that the healthcare cannabis oils Cannbit-Tikun Olam produces – according to Teva’s superior high quality and protection requirements – will enable us notice our aim of increasing the life of sufferers.”
This post initially appeared on Benzinga and has been reposted with permission.